rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Linda M. Szyper

Director

Company insider

Files Form 4 as: Director, Harmony Biosciences Holdings; Director, Neos Therapeutics.

In numbers

Trades disclosed
15
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
2
Companies where not an officer
2
First trade
27 Apr 2018
Last trade
14 May 2026
Last filed
18 May 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
HRMY Harmony Biosciences HoldingsDirector · Pharmaceuticals · last 14 May 20260 buys · 0 sells
Neos TherapeuticsDirector · last 19 Mar 20210 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
14 May 2026filed 18 May 2026HRMY Harmony Biosciences Holdingsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—21,872 at $0.00filing
14 May 2026filed 18 May 2026HRMY Harmony Biosciences Holdingsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—21,872 at $0.00filing
15 May 2025filed 16 May 2025HRMY Harmony Biosciences Holdingsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—14,522 at $0.00filing
29 May 2024filed 31 May 2024HRMY Harmony Biosciences Holdingsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—6,336 at $0.00filing
25 May 2023filed 26 May 2023HRMY Harmony Biosciences Holdingsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—5,224 at $0.00filing
20 May 2022filed 24 May 2022HRMY Harmony Biosciences Holdingsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—4,742 at $0.00filing
18 Nov 2021filed 29 Nov 2021HRMY Harmony Biosciences Holdingsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—5,727 at $0.00filing
19 Mar 2021filed 19 Mar 2021Neos TherapeuticsSEC FORM 4 Code D—23,453filing
19 Mar 2021filed 19 Mar 2021Neos Therapeuticsoption or derivativeSEC FORM 4 Code D—12,500 at $0.00filing
19 Mar 2021filed 19 Mar 2021Neos Therapeuticsoption or derivativeSEC FORM 4 Code D—22,756 at $0.00filing
19 Mar 2021filed 19 Mar 2021Neos Therapeuticsoption or derivativeSEC FORM 4 Code D—46,907 at $0.00filing
10 Jun 2020filed 11 Jun 2020Neos TherapeuticsSEC FORM 4 Code A—23,453 at $0.00filing
13 Jun 2019filed 17 Jun 2019Neos Therapeuticsoption or derivativeSEC FORM 4 Code A—46,907 at $0.00filing
2 Jul 2018filed 3 Jul 2018Neos Therapeuticsoption or derivativeSEC FORM 4 Code A—22,756 at $0.00filing
27 Apr 2018filed 1 May 2018Neos Therapeuticsoption or derivativeSEC FORM 4 Code A—12,500 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Kumar BudurChief Medical Officer · Chief Medical Officer at Harmony Biosciences Holdings, filing Form 4 there in the last year
R. Mark GrafDirector · Director at Harmony Biosciences Holdings, filing Form 4 there in the last year
Geno J. GermanoDirector · Director at Harmony Biosciences Holdings, filing Form 4 there in the last year
Gary SenderDirector · Director at Harmony Biosciences Holdings, filing Form 4 there in the last year
Glenn ReicinChief Financial Officer · Chief Financial Officer at Harmony Biosciences Holdings, filing Form 4 there in the last year